New MS drug VT7208 enters early human testing
Disease control
Recruiting now
This study tests a new drug called VT7208 for multiple sclerosis (MS). It first checks safety and how the drug works in healthy volunteers, then tests it in people with MS. The goal is to see if the drug is safe and how the body processes it. About 100 people will take part.
Phase: PHASE1, PHASE2 • Sponsor: Vidya Therapeutics Inc • Aim: Disease control
Last updated May 14, 2026 12:03 UTC